Posted by Michael Wonder on 22 Jan 2026
Thousands living with lupus offered hope from twice yearly infusion
22 January 2026 - NICE approves breakthrough combination treatment that restores normal kidney function in almost half of patients with lupus nephritis.
The treatment has been approved for NHS use, offering new hope to the nearly 12,000 people in England living with lupus nephritis. Obinutuzumab (Gazyvaro), a twice yearly infusion that, combined with daily immunosuppressant tablets, significantly outperforms the usual treatments for the disease.
